198 related articles for article (PubMed ID: 23574175)
1. Neuropeptide systems and schizophrenia.
LaCrosse AL; Olive MF
CNS Neurol Disord Drug Targets; 2013 Aug; 12(5):619-32. PubMed ID: 23574175
[TBL] [Abstract][Full Text] [Related]
2. Involvement of neuropeptide systems in schizophrenia: human studies.
Cáceda R; Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins.
Griebel G
Curr Pharm Des; 2015; 21(26):3807-12. PubMed ID: 26044977
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptides: implications for alcoholism.
Cowen MS; Chen F; Lawrence AJ
J Neurochem; 2004 Apr; 89(2):273-85. PubMed ID: 15056272
[TBL] [Abstract][Full Text] [Related]
6. Receptors of peptides as therapeutic targets in epilepsy research.
Dobolyi A; Kékesi KA; Juhász G; Székely AD; Lovas G; Kovács Z
Curr Med Chem; 2014; 21(6):764-87. PubMed ID: 24251562
[TBL] [Abstract][Full Text] [Related]
7. Alcoholism and neuropeptides: an update.
Cowen MS; Lawrence AJ
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):233-9. PubMed ID: 16611096
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel G; Holsboer F
Nat Rev Drug Discov; 2012 May; 11(6):462-78. PubMed ID: 22596253
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptides as therapeutic targets in anxiety disorders.
Lin EJ
Curr Pharm Des; 2012; 18(35):5709-27. PubMed ID: 22632474
[TBL] [Abstract][Full Text] [Related]
10. [Role of endogenous neuropeptides in the pathomechanism of alcohol addiction].
Rudzińska U; Zalewska-Kaszubska J
Postepy Hig Med Dosw (Online); 2009 Dec; 63():643-52. PubMed ID: 20097951
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of neuropeptides in rodent models of depression and anxiety.
Rotzinger S; Lovejoy DA; Tan LA
Peptides; 2010 Apr; 31(4):736-56. PubMed ID: 20026211
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.
Hallberg M
Med Res Rev; 2015 May; 35(3):464-519. PubMed ID: 24894913
[TBL] [Abstract][Full Text] [Related]
13. [Neuropeptides in Alzheimer's disease].
Jiménez-Corral C; Morán-Sánchez JC; Alonso-Navarro H
Rev Neurol; 2006 Mar 16-31; 42(6):354-9. PubMed ID: 16575772
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptides and central control of sexual behaviour from the past to the present: a review.
Argiolas A; Melis MR
Prog Neurobiol; 2013 Sep; 108():80-107. PubMed ID: 23851261
[TBL] [Abstract][Full Text] [Related]
15. Are neuropeptides relevant for the mechanism of action of SSRIs?
Gołyszny M; Obuchowicz E
Neuropeptides; 2019 Jun; 75():1-17. PubMed ID: 30824124
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide systems and new treatments for nicotine addiction.
Bruijnzeel AW
Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
[TBL] [Abstract][Full Text] [Related]
17. Presynaptic neuropeptide receptors.
Schlicker E; Kathmann M
Handb Exp Pharmacol; 2008; (184):409-34. PubMed ID: 18064421
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of microinjections of thyrotropin-releasing hormone, oxytocin and other neuropeptides into the rostral ventrolateral medulla of the rat.
Ishizuka T; Wei X; Kubo T
Arch Int Pharmacodyn Ther; 1993; 322():35-44. PubMed ID: 8215715
[TBL] [Abstract][Full Text] [Related]
19. Novel treatments of schizophrenia: targeting the neurotensin system.
Kinkead B; Nemeroff CB
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):205-18. PubMed ID: 16611093
[TBL] [Abstract][Full Text] [Related]
20. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides.
Holmqvist T; Akerman KE; Kukkonen JP
Neurosci Lett; 2001 Jun; 305(3):177-80. PubMed ID: 11403934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
